1. Home
  2. GNPX
  3. GNPX News

Latest Genprex Inc. (GNPX) News on July 27, 2024

Genprex Issues Stockholder Letter and Provides 2024 Corporate Update
GNPX

PR Newswire

a month ago

Genprex Issues Stockholder Letter and Provides 2024 Corporate Update

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities
GNPX

PR Newswire

2 months ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

GNPX

Business Wire

2 months ago

Form 8.3 - International Distribution Services plc

GNPX

Business Wire

2 months ago

Form 8.3 - Darktrace plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win
GNPX

Reuters

2 months ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect
GNPX

Investor's Business Daily

2 months ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina
GNPX

Business Wire

2 months ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

GNPX

GlobeNewswire

2 months ago

Middlefield Canadian Income PCC: Net Asset Value(s)

GNPX

Business Wire

2 months ago

Form 8.3 - International Paper Company

GNPX

Business Wire

2 months ago

Net Asset Value(s)

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon
GNPX

Newsfile

2 months ago

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%
GNPX

GlobeNewswire

2 months ago

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
GNPX

GlobeNewswire

2 months ago

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence
GNPX

Business Wire

2 months ago

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities
GNPX

Business Wire

2 months ago

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Dstny honored with 'Employee Wellbeing Award'
GNPX

PR Newswire

2 months ago

Dstny honored with 'Employee Wellbeing Award'

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024
GNPX

PR Newswire

2 months ago

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

GNPX

Journal-News, Hamilton, Ohio

2 months ago

Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now
GNPX

Motley Fool

2 months ago

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs
GNPX

TechCrunch

2 months ago

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

Italian energy company targets Britain for fleet of 20 mini-nukes
GNPX

The Telegraph

2 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
GNPX

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Saudis Said to Hand About 60% of Aramco Offer to Foreigners
GNPX

Bloomberg

2 months ago

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
GNPX

Simply Wall St.

2 months ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
GNPX

Simply Wall St.

2 months ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Genprex to Present at the 2024 BIO International Convention
GNPX

PR Newswire

2 months ago

Genprex to Present at the 2024 BIO International Convention

Genprex dosing subjects in trial of combination therapy for small-cell lung cancer
GNPX

Clinical Trials Arena

2 months ago

Genprex dosing subjects in trial of combination therapy for small-cell lung cancer

Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
GNPX

PR Newswire

2 months ago

Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors
GNPX

PR Newswire

2 months ago

Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors

Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
GNPX

PR Newswire

3 months ago

Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner

Sidoti Events, LLC's Virtual May Micro-Cap Conference
GNPX

ACCESSWIRE

3 months ago

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Genprex to Present and Participate at Upcoming May Investor and Industry Conferences
GNPX

PR Newswire

3 months ago

Genprex to Present and Participate at Upcoming May Investor and Industry Conferences

Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
GNPX

PR Newswire

4 months ago

Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting

Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up
GNPX

Zacks

4 months ago

Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up

Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
GNPX

PR Newswire

4 months ago

Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System
GNPX

PR Newswire

4 months ago

Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System

Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GNPX

PR Newswire

4 months ago

Genprex Announces Closing of $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GNPX

PR Newswire

4 months ago

Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GNPX

PR Newswire

4 months ago

Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa® Immunogene Therapy with PD-1 and PD-L1 Antibodies to Treat Cancers
GNPX

PR Newswire

4 months ago

Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa® Immunogene Therapy with PD-1 and PD-L1 Antibodies to Treat Cancers

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
GNPX

PR Newswire

5 months ago

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting

Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators
GNPX

PR Newswire

6 months ago

Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators

Genprex to Present at Upcoming BIO CEO & Investor Conference
GNPX

PR Newswire

6 months ago

Genprex to Present at Upcoming BIO CEO & Investor Conference

Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
GNPX

PR Newswire

6 months ago

Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer

2U Partners with University of Surrey to Launch 15 Online Master's Degrees
GNPX

PR Newswire

6 months ago

2U Partners with University of Surrey to Launch 15 Online Master's Degrees

Genprex Announces 1-for-40 Reverse Stock Split Effective February 2, 2024
GNPX

PR Newswire

6 months ago

Genprex Announces 1-for-40 Reverse Stock Split Effective February 2, 2024

15 Cash-Rich Penny Stocks Hedge Funds Are Buying
GNPX

Insider Monkey

6 months ago

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
GNPX

GlobeNewswire

6 months ago

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
GNPX

GlobeNewswire

6 months ago

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

LED Lighting, EV Charging and Electrical Maintenance Provider Orion Announces Preliminary Q3’24 Revenue Growing to $25.8M-$26.2M and Improved Cash Position; Updates FY 2024 Anticipated Revenue Outlook to $90M-$95M
GNPX

GlobeNewswire

6 months ago

LED Lighting, EV Charging and Electrical Maintenance Provider Orion Announces Preliminary Q3’24 Revenue Growing to $25.8M-$26.2M and Improved Cash Position; Updates FY 2024 Anticipated Revenue Outlook to $90M-$95M

Sidoti Events, LLC's Virtual January Micro-Cap Conference
GNPX

ACCESSWIRE

6 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding
GNPX

GuruFocus.com

7 months ago

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India
GNPX

Business Wire

7 months ago

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

GrowGeneration Provides Full-Year 2023 Guidance Update Ahead of the 26th Annual ICR Conference
GNPX

Business Wire

7 months ago

GrowGeneration Provides Full-Year 2023 Guidance Update Ahead of the 26th Annual ICR Conference

United Natural (UNFI) Down 1.8% Since Last Earnings Report: Can It Rebound?
GNPX

Zacks

7 months ago

United Natural (UNFI) Down 1.8% Since Last Earnings Report: Can It Rebound?

Unity Bancorp (UNTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
GNPX

Zacks

7 months ago

Unity Bancorp (UNTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Genprex Provides Business Update and Outlook for 2024
GNPX

PR Newswire

7 months ago

Genprex Provides Business Update and Outlook for 2024

Why Novo Nordisk Stock Crushed the Market Today
GNPX

Motley Fool

7 months ago

Why Novo Nordisk Stock Crushed the Market Today

Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
GNPX

Business Wire

7 months ago

Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024

3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio
GNPX

Zacks

7 months ago

3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio

Velo3D, Inc. Enters Debt Amendment Agreement with Existing Note Holder
GNPX

Business Wire

7 months ago

Velo3D, Inc. Enters Debt Amendment Agreement with Existing Note Holder

Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stock
GNPX

Zacks

7 months ago

Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stock

OKO Digital Announces Strategic Partnership With Loop Media
GNPX

PR Newswire

7 months ago

OKO Digital Announces Strategic Partnership With Loop Media

POET Technologies Announces Non-Brokered Private Placement
GNPX

GlobeNewswire

8 months ago

POET Technologies Announces Non-Brokered Private Placement

GNPX

Associated Press Finance

8 months ago

Delta Apparel: Fiscal Q4 Earnings Snapshot

Delta Apparel Reports Fourth Quarter and Full Year Fiscal 2023 Results
GNPX

Business Wire

8 months ago

Delta Apparel Reports Fourth Quarter and Full Year Fiscal 2023 Results

Those who invested in Full House Resorts (NASDAQ:FLL) five years ago are up 145%
GNPX

Simply Wall St.

8 months ago

Those who invested in Full House Resorts (NASDAQ:FLL) five years ago are up 145%

Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia
GNPX

GlobeNewswire

8 months ago

Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia

Powerfleet Named a Top Innovator by ABI Research
GNPX

PR Newswire

8 months ago

Powerfleet Named a Top Innovator by ABI Research

Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium
GNPX

PR Newswire

8 months ago

Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium

Altisource Portfolio Solutions (NASDAQ:ASPS) investors are sitting on a loss of 81% if they invested five years ago
GNPX

Simply Wall St.

8 months ago

Altisource Portfolio Solutions (NASDAQ:ASPS) investors are sitting on a loss of 81% if they invested five years ago

GNPX

PR Newswire

8 months ago

Jewett-Cameron Announces Fiscal 2023 Financial Results

How Much Upside is Left in Enanta Pharmaceuticals (ENTA)? Wall Street Analysts Think 88.23%
GNPX

Zacks

8 months ago

How Much Upside is Left in Enanta Pharmaceuticals (ENTA)? Wall Street Analysts Think 88.23%

Is Red Violet (RDVT) Going to Stay Flat Forever?
GNPX

Insider Monkey

8 months ago

Is Red Violet (RDVT) Going to Stay Flat Forever?

Genprex Granted Orphan Drug Designation in Small Cell Lung Cancer
GNPX

NewMediaWire

8 months ago

Genprex Granted Orphan Drug Designation in Small Cell Lung Cancer

These Cathie Wood Stocks Are On Sale Now
GNPX

Insider Monkey

8 months ago

These Cathie Wood Stocks Are On Sale Now

When Can We Expect A Profit From YS Biopharma Co., Ltd. (NASDAQ:YS)?
GNPX

Simply Wall St.

8 months ago

When Can We Expect A Profit From YS Biopharma Co., Ltd. (NASDAQ:YS)?

Advantage Solutions releases 2023 Private Brand Intelligence Report
GNPX

GlobeNewswire

8 months ago

Advantage Solutions releases 2023 Private Brand Intelligence Report

NOVONIX (ASX:NVX) shareholders have endured a 72% loss from investing in the stock a year ago
GNPX

Simply Wall St.

8 months ago

NOVONIX (ASX:NVX) shareholders have endured a 72% loss from investing in the stock a year ago

BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors
GNPX

GlobeNewswire

9 months ago

BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors

Share on Social Networks: